The trajectory of Sildenafil presents a intricate picture for investors. While the initial introduction generated substantial returns, the lapse of its patent opened the door to generic competitors, dramatically https://tealbookmarks.com/story21612783/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity